Close
ACHEMA MIDDLE EAST 2026

Asthma: U.S. FDA approves new indication for SPIRIVA® Respimat®

U.S. FDA latest regulatory authority to approve SPIRIVA® (tiotropium) Respimat® in asthma1 following authorities in the EU, Japan and other countriesRecent GINA 2015 Global...

Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Jardiance® achieved superiority for the primary CV endpoint and a significant reduction in CV death in people with T2D at high risk of CV...

Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD

• Aims to identify novel epigenetic drivers to find new approaches for treating COPD• Crowdsourcing used to find unconventional solutions and identify the best...

Boehringer Ingelheim Animal Health launches two new swine vaccines in Europe

New vaccines Ingelvac PRRSFLEX® EU for piglets and ReproCyc® PRRS EU for sows offer sustainable control of Porcine Reproductive and Respiratory Syndrome (PRRS). Boehringer...

US FDA grants breakthrough therapy designation for Roche’s investigational medicine ACE910 for people with haemophilia A with factor VIII inhibitors

First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of haemophilia A Ninth breakthrough therapy designation for Roche’s portfolio of medicines1-6 Roche (SIX:...

Roche receives FDA CLIA waiver for flu A/B test for use on its cobas Liat PCR System

First CLIA-waived, real-time PCR tests for flu and Strep A now available for physician offices and pharmaciesRoche (SIX: RO, ROG; OTCQX: RHHBY) today announced...

Vyome Biosciences Presents Research Data on Development of Novel Antibiotics and Antifungal Agents to American Society of Microbiology

Vyome Biosciences, a dermatology based innovative bio-pharmaceutical company, which is pioneering the development of next generation antibiotics and antifungal agents that target antimicrobial resistance...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...